178 related articles for article (PubMed ID: 38720803)
21. Structural characterization of the LEM motif common to three human inner nuclear membrane proteins.
Laguri C; Gilquin B; Wolff N; Romi-Lebrun R; Courchay K; Callebaut I; Worman HJ; Zinn-Justin S
Structure; 2001 Jun; 9(6):503-11. PubMed ID: 11435115
[TBL] [Abstract][Full Text] [Related]
22. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
Ring A; Kaur P; Lang JE
BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
[TBL] [Abstract][Full Text] [Related]
23. Purification and Structural Analysis of LEM-Domain Proteins.
Herrada I; Bourgeois B; Samson C; Buendia B; Worman HJ; Zinn-Justin S
Methods Enzymol; 2016; 569():43-61. PubMed ID: 26778552
[TBL] [Abstract][Full Text] [Related]
24. LEM Domain Containing 1 Acts as a Novel Oncogene and Therapeutic Target for Triple-Negative Breast Cancer.
Li X; Jiang S; Jiang T; Sun X; Guan Y; Fan S; Cheng Y
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296887
[TBL] [Abstract][Full Text] [Related]
25. Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in
Hu ZY; Zheng C; Yang J; Ding S; Tian C; Xie N; Xue L; Wu M; Fu S; Rao Z; Price MA; McCarthy JB; Ouyang Q; Lin J; Deng X
Front Oncol; 2022; 12():804466. PubMed ID: 35280756
[TBL] [Abstract][Full Text] [Related]
26. Tissue-specific defects are caused by loss of the Drosophila MAN1 LEM domain protein.
Pinto BS; Wilmington SR; Hornick EE; Wallrath LL; Geyer PK
Genetics; 2008 Sep; 180(1):133-45. PubMed ID: 18723885
[TBL] [Abstract][Full Text] [Related]
27. Direct binding of nuclear membrane protein MAN1 to emerin in vitro and two modes of binding to barrier-to-autointegration factor.
Mansharamani M; Wilson KL
J Biol Chem; 2005 Apr; 280(14):13863-70. PubMed ID: 15681850
[TBL] [Abstract][Full Text] [Related]
28. Checkpoint activation drives global gene expression changes in Drosophila nuclear lamina mutants.
Kitzman SC; Duan T; Pufall MA; Geyer PK
G3 (Bethesda); 2022 Feb; 12(2):. PubMed ID: 34893833
[TBL] [Abstract][Full Text] [Related]
29. Beyond Tethering and the LEM domain: MSCellaneous functions of the inner nuclear membrane Lem2.
Braun S; Barrales RR
Nucleus; 2016 Nov; 7(6):523-531. PubMed ID: 27797637
[TBL] [Abstract][Full Text] [Related]
30. CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer.
Black JL; Harrell JC; Leisner TM; Fellmeth MJ; George SD; Reinhold D; Baker NM; Jones CD; Der CJ; Perou CM; Parise LV
Breast Cancer Res Treat; 2015 Jul; 152(2):337-46. PubMed ID: 26105795
[TBL] [Abstract][Full Text] [Related]
31. All in the family: evidence for four new LEM-domain proteins Lem2 (NET-25), Lem3, Lem4 and Lem5 in the human genome.
Lee KK; Wilson KL
Symp Soc Exp Biol; 2004; (56):329-39. PubMed ID: 15565891
[TBL] [Abstract][Full Text] [Related]
32. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
[TBL] [Abstract][Full Text] [Related]
33. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
34. Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1.
Cınar V; Hamurcu Z; Guler A; Nurdinov N; Ozpolat B
Breast Cancer; 2022 Nov; 29(6):1106-1120. PubMed ID: 36006564
[TBL] [Abstract][Full Text] [Related]
35. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
[TBL] [Abstract][Full Text] [Related]
36. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
37. MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival.
Grieb BC; Chen X; Eischen CM
Mol Cancer Res; 2014 Sep; 12(9):1216-24. PubMed ID: 24866769
[TBL] [Abstract][Full Text] [Related]
38. MAN1 and emerin have overlapping function(s) essential for chromosome segregation and cell division in Caenorhabditis elegans.
Liu J; Lee KK; Segura-Totten M; Neufeld E; Wilson KL; Gruenbaum Y
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4598-603. PubMed ID: 12684533
[TBL] [Abstract][Full Text] [Related]
39. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
40. The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
Qian J; Ma Y; Tahaney WM; Moyer CL; Lanier A; Hill J; Coleman D; Koupaei N; Hilsenbeck SG; Savage MI; Page BDG; Mazumdar A; Brown PH
Breast Cancer Res; 2024 Feb; 26(1):23. PubMed ID: 38317231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
